Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Genometry commercialized the L1000 assay, a high-throughput gene-expression profiling technology developed at the Broad Institute. The platform measures approximately 1,000 landmark genes to accurately estimate the activity of all ~20,000 genes expressed in a cell, operating at a fraction of the cost of conventional methods (a few dollars per sample versus $500)[2]. The assay enables pharmaceutical companies to rapidly screen and characterize large compound libraries, with applications in drug discovery, hit selection, and compound prioritization[2].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Genometry.